These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28921443)

  • 1. Polyester-Based Nanoparticles for the Encapsulation of Monoclonal Antibodies.
    Sousa F; Fonte P; Cruz A; Kennedy PJ; Pinto IM; Sarmento B
    Methods Mol Biol; 2018; 1674():239-253. PubMed ID: 28921443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyester-Based Nanoparticles for Delivery of Therapeutic Proteins.
    Fonte P; Sousa F; Sarmento B
    Methods Mol Biol; 2018; 1674():255-274. PubMed ID: 28921444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
    Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
    Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biodegradable nanocarriers loaded with a monoclonal antibody.
    Gdowski A; Ranjan A; Mukerjee A; Vishwanatha J
    Int J Mol Sci; 2015 Feb; 16(2):3990-5. PubMed ID: 25690029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
    Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
    Cirstoiu-Hapca A; Buchegger F; Bossy L; Kosinski M; Gurny R; Delie F
    Eur J Pharm Sci; 2009 Oct; 38(3):230-7. PubMed ID: 19632322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?
    Sousa F; Castro P; Fonte P; Kennedy PJ; Neves-Petersen MT; Sarmento B
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1163-1176. PubMed ID: 28005451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide.
    Bahari Javan N; Montazeri H; Rezaie Shirmard L; Jafary Omid N; Barbari GR; Amini M; Ghahremani MH; Rafiee-Tehrani M; Abedin Dorkoosh F
    Eur J Pharm Sci; 2017 Apr; 101():167-181. PubMed ID: 28193537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
    Papadimitriou S; Bikiaris D
    J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery.
    Suktham K; Koobkokkruad T; Wutikhun T; Surassmo S
    Int J Pharm; 2018 Feb; 537(1-2):48-56. PubMed ID: 29229512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation and controlled release of a hydrophobic drug using a novel nanoparticle-forming hyperbranched polyester.
    Zou J; Shi W; Wang J; Bo J
    Macromol Biosci; 2005 Jul; 5(7):662-8. PubMed ID: 16001454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles.
    Ashwanikumar N; Kumar NA; Asha Nair S; Vinod Kumar GS
    Acta Biomater; 2014 Nov; 10(11):4685-4694. PubMed ID: 25110286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Blanco MD
    Anticancer Drugs; 2012 Oct; 23(9):947-58. PubMed ID: 22713593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone.
    Yameen B; Vilos C; Choi WI; Whyte A; Huang J; Pollit L; Farokhzad OC
    Chemistry; 2015 Aug; 21(32):11325-9. PubMed ID: 26177931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles.
    Debotton N; Parnes M; Kadouche J; Benita S
    J Control Release; 2008 May; 127(3):219-30. PubMed ID: 18343522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ε-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release.
    Kaffashi B; Davoodi S; Oliaei E
    Int J Pharm; 2016 Jul; 508(1-2):10-21. PubMed ID: 27155590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
    Keloglu N; Verrier B; Trimaille T; Sohier J
    Colloids Surf B Biointerfaces; 2016 Apr; 140():142-149. PubMed ID: 26752211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.